chr7-105532352-G-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_021930.6(RINT1):​c.37G>T​(p.Ala13Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A13V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

RINT1
NM_021930.6 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0590

Publications

0 publications found
Variant links:
Genes affected
RINT1 (HGNC:21876): (RAD50 interactor 1) This gene encodes a protein first identified for its ability to interact with the RAD50 double strand break repair protein, with the resulting interaction implicated in the regulation of cell cycle progression and telomere length. The encoded protein may also play a role in trafficking of cellular cargo from the endosome to the trans-Golgi network. Mutations in this gene may be associated with breast cancer in human patients. [provided by RefSeq, Oct 2016]
RINT1 Gene-Disease associations (from GenCC):
  • infantile liver failure syndrome 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile liver failure syndrome 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06706315).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RINT1NM_021930.6 linkc.37G>T p.Ala13Ser missense_variant Exon 1 of 15 ENST00000257700.7 NP_068749.3 Q6NUQ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RINT1ENST00000257700.7 linkc.37G>T p.Ala13Ser missense_variant Exon 1 of 15 1 NM_021930.6 ENSP00000257700.2 Q6NUQ1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1448854
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
719996
African (AFR)
AF:
0.00
AC:
0
AN:
33278
American (AMR)
AF:
0.00
AC:
0
AN:
43424
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25834
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49798
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5728
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1107460
Other (OTH)
AF:
0.00
AC:
0
AN:
59898
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 28, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A13S variant (also known as c.37G>T), located in coding exon 1 of the RINT1 gene, results from a G to T substitution at nucleotide position 37. The alanine at codon 13 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.3
DANN
Benign
0.95
DEOGEN2
Benign
0.044
T;.
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.072
N
LIST_S2
Benign
0.69
T;T
M_CAP
Benign
0.0068
T
MetaRNN
Benign
0.067
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
0.059
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.32
N;N
REVEL
Benign
0.064
Sift
Benign
0.064
T;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0
B;.
Vest4
0.086
MutPred
0.12
Gain of glycosylation at A13 (P = 0.0089);Gain of glycosylation at A13 (P = 0.0089);
MVP
0.25
MPC
0.17
ClinPred
0.12
T
GERP RS
-0.23
PromoterAI
-0.027
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.063
gMVP
0.15
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1241302881; hg19: chr7-105172799; API